By Arkady Petrov
RIO DE JANEIRO, BRAZIL - The total number of people registered to benefit from prevention through Pre-Exposure Prophylaxis (PrEP), a drug preventing HIV infection, increased by 38 percent in five months. The treatment has been available since January 2018 in the . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here